Home/Filings/4/A/0001610618-21-000097
4/A//SEC Filing

Johnson Brady 4/A

Accession 0001610618-21-000097

CIK 0001610618other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 9:26 PM ET

Size

5.0 KB

Accession

0001610618-21-000097

Insider Transaction Report

Form 4/AAmended
Period: 2021-09-30
Johnson Brady
Dir. of Finance & Controller
Transactions
  • Award

    Common Stock

    2021-09-30+20,75047,119 total
Footnotes (2)
  • [F1]All RSUs vest in three equal annual installments, with 1/3 vesting on each of September 10, 2022, 2023, and 2024, subject to continuous service through each such vesting date.
  • [F2]This amendment is being filed to correct the end of period holdings which were overstated by 80 shares.

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1
  • filerCIK 0001751478

Filing Metadata

Form type
4/A
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 9:26 PM ET
Size
5.0 KB